RxNorm 1151668
Benzalkonium-containing product in cutaneous dose form
RxNorm Semantic Concepts
RxNorm semantic concepts for the RxCUI 1151668 unique identifier include: benzalkonium Topical Product (12286340), Benzalkonium-containing product in cutaneous dose form (10797671) and Product containing benzalkonium in cutaneous dose form (medicinal product form) (10810079).
RxNorm Atom ID: 12286340 - Semantic Clinical Dose Form Group
benzalkonium Topical Product
- RXCUI:
- 1151668 - RxNorm Unique Identifier for a concept (Concept ID)
- LAT:
- ENG - Language of the Term
- RXAUI:
- 12286340 - Unique identifier for the atom (RxNorm Atom ID)
- Is Prescribable?
- YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
- Concept Description:
- benzalkonium Topical Product - Description of concept identifier
- Term Type (TTY):
- SCDG - Term type in source with name and description
- Term Type Name:
- Semantic Clinical Dose Form Group - Name of term type in source
- Term Type Description:
- Ingredient + Dose Form Group - Description of term type in source
- Code:
- 1151668 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
- Suppress Flag:
- N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility. - CVF:
- 4096 - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
- Source:
- RXNORM - Concept source abbreviation
- Source Name:
- RxNorm Vocabulary - The official name for a source
- Source Version:
- 20AA_240401F - The source version
- Source Date:
- March 04, 2024 - RxNorm data last updated
- Source License Contact:
- RxNorm Customer Service
U.S. National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
(888) FIND-NLM
[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source license contact information - Source Content Contact:
- RxNorm Customer Service
U.S. National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
(888) FIND-NLM
[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source content contact information - Source Short Name:
- RxNorm work done by the National Library of Medicine - The short name of a source as used by the NLM Knowledge Source Server
RxNorm Atom 12286340 Attributes
Property | Value | Explanation |
---|---|---|
RXN AVAILABLE STRENGTH | 0.00095 MG/MG | Available drug strengths listed in the order of ingredients from the drug |
RXN AVAILABLE STRENGTH | 0.00125 MG/MG (expressed as benzalkonium chloride) | Available drug strengths listed in the order of ingredients from the drug |
RXN AVAILABLE STRENGTH | 0.0013 MG/MG | Available drug strengths listed in the order of ingredients from the drug |
RXN AVAILABLE STRENGTH | 0.001 MG/MG | Available drug strengths listed in the order of ingredients from the drug |
RXN AVAILABLE STRENGTH | 0.003 MG/MG (expressed as benzalkonium chloride) | Available drug strengths listed in the order of ingredients from the drug |
RXN AVAILABLE STRENGTH | 0.11 MG/ML | Available drug strengths listed in the order of ingredients from the drug |
RXN AVAILABLE STRENGTH | 0.5 MG/ML (expressed as benzalkonium chloride) | Available drug strengths listed in the order of ingredients from the drug |
RXN AVAILABLE STRENGTH | 0.8 MG/ML (expressed as benzalkonium chloride) | Available drug strengths listed in the order of ingredients from the drug |
RXN AVAILABLE STRENGTH | 0.9 MG/ML (expressed as benzalkonium chloride) | Available drug strengths listed in the order of ingredients from the drug |
RXN AVAILABLE STRENGTH | 1.15 MG/ML | Available drug strengths listed in the order of ingredients from the drug |
RXN AVAILABLE STRENGTH | 1.1 MG/ML | Available drug strengths listed in the order of ingredients from the drug |
RXN AVAILABLE STRENGTH | 1.21 MG/ML (expressed as benzalkonium chloride) | Available drug strengths listed in the order of ingredients from the drug |
RXN AVAILABLE STRENGTH | 1.25 MG/ML | Available drug strengths listed in the order of ingredients from the drug |
RXN AVAILABLE STRENGTH | 1.2 MG/ML | Available drug strengths listed in the order of ingredients from the drug |
RXN AVAILABLE STRENGTH | 1.33 MG/ML | Available drug strengths listed in the order of ingredients from the drug |
RXN AVAILABLE STRENGTH | 1.35 MG/ML (expressed as benzalkonium chloride) | Available drug strengths listed in the order of ingredients from the drug |
RXN AVAILABLE STRENGTH | 1.3 MG/ML | Available drug strengths listed in the order of ingredients from the drug |
RXN AVAILABLE STRENGTH | 1.4 MG/ML (expressed as benzalkonium chloride) | Available drug strengths listed in the order of ingredients from the drug |
RXN AVAILABLE STRENGTH | 1.55 MG/ML | Available drug strengths listed in the order of ingredients from the drug |
RXN AVAILABLE STRENGTH | 1.5 MG/ML | Available drug strengths listed in the order of ingredients from the drug |
RXN AVAILABLE STRENGTH | 170 MG/ML | Available drug strengths listed in the order of ingredients from the drug |
RXN AVAILABLE STRENGTH | 1 MG/ML | Available drug strengths listed in the order of ingredients from the drug |
RXN AVAILABLE STRENGTH | 2.3 MG/ML (expressed as benzalkonium chloride) | Available drug strengths listed in the order of ingredients from the drug |
RXN AVAILABLE STRENGTH | 2.6 MG/ML (expressed as benzalkonium chloride) | Available drug strengths listed in the order of ingredients from the drug |
RXN AVAILABLE STRENGTH | 2 MG/ML (expressed as benzalkonium chloride) | Available drug strengths listed in the order of ingredients from the drug |
RXN AVAILABLE STRENGTH | 2 MG/ML | Available drug strengths listed in the order of ingredients from the drug |
RXN AVAILABLE STRENGTH | 3 MG/ML | Available drug strengths listed in the order of ingredients from the drug |
RXN AVAILABLE STRENGTH | 4 MG/ML | Available drug strengths listed in the order of ingredients from the drug |
RXN AVAILABLE STRENGTH | 5 MG/ML (expressed as benzalkonium chloride) | Available drug strengths listed in the order of ingredients from the drug |
RXN AVAILABLE STRENGTH | 8.9 MG/ML | Available drug strengths listed in the order of ingredients from the drug |
RxNorm Atom ID: 10797671 - Designated preferred name
Benzalkonium-containing product in cutaneous dose form
- RXCUI:
- 1151668 - RxNorm Unique Identifier for a concept (Concept ID)
- LAT:
- ENG - Language of the Term
- RXAUI:
- 10797671 - Unique identifier for the atom (RxNorm Atom ID)
- Is Prescribable?
- YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
- Concept Description:
- Benzalkonium-containing product in cutaneous dose form - Description of concept identifier
- Term Type (TTY):
- PT - Term type in source with name and description
- Term Type Name:
- Designated preferred name - Name of term type in source
- Term Type Description:
- - Description of term type in source
- Code:
- 771779004 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
- Suppress Flag:
- N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility. - CVF:
- - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
- Source:
- SNOMEDCT_US - Concept source abbreviation
- Source Name:
- US Edition of SNOMED CT - The official name for a source
- Source Version:
- 2024_01_01 - The source version
- Source Date:
- March 04, 2024 - RxNorm data last updated
- Source License Contact:
- National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)
https://support.nlm.nih.gov/support/create-case/
- The source license contact information - Source Content Contact:
- National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library Of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)
https://support.nlm.nih.gov/support/create-case/
- The source content contact information - Source Short Name:
- US Edition of SNOMED CT - The short name of a source as used by the NLM Knowledge Source Server
RxNorm Atom ID: 10810079 - Full form of descriptor
Product containing benzalkonium in cutaneous dose form (medicinal product form)
- RXCUI:
- 1151668 - RxNorm Unique Identifier for a concept (Concept ID)
- LAT:
- ENG - Language of the Term
- RXAUI:
- 10810079 - Unique identifier for the atom (RxNorm Atom ID)
- Is Prescribable?
- YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
- Concept Description:
- Product containing benzalkonium in cutaneous dose form (medicinal product form) - Description of concept identifier
- Term Type (TTY):
- FN - Term type in source with name and description
- Term Type Name:
- Full form of descriptor - Name of term type in source
- Term Type Description:
- - Description of term type in source
- Code:
- 771779004 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
- Suppress Flag:
- N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility. - CVF:
- - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
- Source:
- SNOMEDCT_US - Concept source abbreviation
- Source Name:
- US Edition of SNOMED CT - The official name for a source
- Source Version:
- 2024_01_01 - The source version
- Source Date:
- March 04, 2024 - RxNorm data last updated
- Source License Contact:
- National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)
https://support.nlm.nih.gov/support/create-case/
- The source license contact information - Source Content Contact:
- National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library Of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)
https://support.nlm.nih.gov/support/create-case/
- The source content contact information - Source Short Name:
- US Edition of SNOMED CT - The short name of a source as used by the NLM Knowledge Source Server
* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.